Remarkably, mutant KRAS suppression leads to an increased autophagic flux rather than decreased basal levels, and the chronic ablation of KRASG12D results, in mouse pancreatic ductal carcinoma cells, in more dependence on autophagy. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.